Sprott Focus Trust, Inc.
Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Third Quarter Common Stock Distribution of $0.10 Per Share
TORONTO, Sept. 4, 2015 (GLOBE NEWSWIRE) -- Sprott Focus Trust, Inc. (Nasdaq:FUND) (the "Fund" or "FUND") has declared a quarterly distribution of $0.10 per share on its Common Stock. The distribution, optionally payable in additional shares of Common Stock or in cash by specific stockholder election, is to be paid on September 28, 2015 to stockholders of record at the close of business on September 15, 2015 (ex-dividend on September 11, 2015). The price of shares issued for reinvestment will be determined on September 22, 2015.
U.S. FDA Grants Priority Review for Daratumumab for Double Refractory Multiple Myeloma
-- U.S. FDA grants Priority Review to daratumumab
-- PDUFA target date has been set to March 9, 2016
Copenhagen, Denmark; September 4, 2015 – Genmab A/S (OMX: GEN) announced today
that the U.S. Food and Drug Administration (FDA) has granted Priority Review to
the Biologics License Application (BLA) for daratumumab. The BLA is for
daratumumab as a treatment for patients with multiple myeloma who have received
at least three different lines of therapy including bot
Merger of Landsbankinn and Sparisjóður Norðurlands approved
The merger of Landsbankinn and Sparisjóður Norðurlands has now been approved by
regulators and will formally take effect as of today, 4 September 2015. At its
meeting earlier today, the Board of Directors of Landsbankinn agreed to the
merger on behalf of the Bank. A meeting of the guarantee capital owners of the
savings bank had previously approved the merger.
The merged company will operate under Landsbankinn's name, all employees of the
savings bank will be Landsbankinn's employees, all ass